glp 1 death rate Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes The GLP-1 Access Gap: Mapping

& Sandi, C

It is more of a direct penetration into the bloodstream and is thus more efficient and total

Realistic expectation: users typically see appetite reduction and measurable weight changes within weeks, while full effects develop over months

Furthermore, there arent any plausible pharmacological mechanisms to support such effects

Patients should also seek evaluation if they experience numbness, tingling, or color changes in fingers and toes (particularly white, blue, or red discoloration), which could indicate peripheral vascular issues or Raynaud's phenomenon rather than simple cold sensitivity

Healthy eating and physical activity improve results and long term success